Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	gamma-delta T cell receptor complex	TRGC1 TRGC2	3.18e-05	6	31	2	GO:0042106
GeneOntologyCellularComponent	NLS-dependent protein nuclear import complex	KPNA4 KPNA3	9.51e-05	10	31	2	GO:0042564
GeneOntologyCellularComponent	nucleocytoplasmic transport complex	KPNA4 KPNA3	1.39e-04	12	31	2	GO:0031074
GeneOntologyCellularComponent	receptor complex	PLA2R1 SCIMP TRGC1 TRGC2 CHUK	1.52e-03	581	31	5	GO:0043235
MousePheno	epidermal desquamation	ABCA12 CHUK	2.36e-05	5	22	2	MP:0001230
Domain	Arm_3	KPNA4 KPNA3	4.87e-05	7	29	2	PF16186
Domain	Importing_su_alpha	KPNA4 KPNA3	4.87e-05	7	29	2	IPR024931
Domain	Arm_3	KPNA4 KPNA3	4.87e-05	7	29	2	IPR032413
Domain	IBB	KPNA4 KPNA3	4.87e-05	7	29	2	PF01749
Domain	IBB	KPNA4 KPNA3	6.48e-05	8	29	2	PS51214
Domain	Importin-a_IBB	KPNA4 KPNA3	8.32e-05	9	29	2	IPR002652
Domain	ARM-type_fold	KPNA4 PPP2R1A CLTCL1 MROH2A KPNA3	1.59e-04	339	29	5	IPR016024
Domain	RCC1	HERC3 HERC4	4.35e-04	20	29	2	PF00415
Domain	RCC1_3	HERC3 HERC4	4.80e-04	21	29	2	PS50012
Domain	RCC1_1	HERC3 HERC4	4.80e-04	21	29	2	PS00625
Domain	RCC1_2	HERC3 HERC4	4.80e-04	21	29	2	PS00626
Domain	Reg_chr_condens	HERC3 HERC4	5.27e-04	22	29	2	IPR000408
Domain	-	HERC3 HERC4	5.27e-04	22	29	2	2.130.10.30
Domain	RCC1/BLIP-II	HERC3 HERC4	5.77e-04	23	29	2	IPR009091
Domain	ARM-like	KPNA4 PPP2R1A MROH2A KPNA3	7.63e-04	270	29	4	IPR011989
Domain	HECT	HERC3 HERC4	7.98e-04	27	29	2	PF00632
Domain	HECTc	HERC3 HERC4	7.98e-04	27	29	2	SM00119
Domain	HECT_dom	HERC3 HERC4	7.98e-04	27	29	2	IPR000569
Domain	HECT	HERC3 HERC4	7.98e-04	27	29	2	PS50237
Domain	Arm	KPNA4 KPNA3	1.05e-03	31	29	2	PF00514
Domain	ARM	KPNA4 KPNA3	1.75e-03	40	29	2	SM00185
Domain	ARM_REPEAT	KPNA4 KPNA3	1.75e-03	40	29	2	PS50176
Domain	Armadillo	KPNA4 KPNA3	2.41e-03	47	29	2	IPR000225
Domain	Quinoprotein_ADH-like_supfam	PREB EML5	3.05e-03	53	29	2	IPR011047
Domain	-	KPNA4 PPP2R1A KPNA3	4.82e-03	222	29	3	1.25.10.10
Domain	HEAT_REPEAT	PPP2R1A MROH2A	5.27e-03	70	29	2	PS50077
Pathway	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	KPNA4 PPP2R1A CHUK KPNA3	4.33e-05	151	19	4	M550
Pathway	BIOCARTA_NFKB_PATHWAY	IL1R1 CHUK	3.56e-04	21	19	2	MM1444
Pathway	BIOCARTA_RAS_PATHWAY	PLD1 CHUK	3.56e-04	21	19	2	MM1464
Pathway	BIOCARTA_NFKB_PATHWAY	IL1R1 CHUK	3.56e-04	21	19	2	M15285
Pathway	BIOCARTA_RAS_PATHWAY	PLD1 CHUK	3.91e-04	22	19	2	M17294
Pathway	REACTOME_INTERFERON_SIGNALING	KPNA4 PPP2R1A CHUK KPNA3	4.24e-04	273	19	4	M983
Pubmed	Structure, organization, and somatic rearrangement of T cell gamma genes.	TRGC1 TRGC2	7.69e-07	2	31	2	3917858
Pubmed	Allelic differences in TCR gamma-chains alter gamma delta T cell antigen reactivity.	TRGC1 TRGC2	7.69e-07	2	31	2	8046225
Pubmed	Polymorphism of Tcrb and Tcrg genes in Biozzi mice: segregation analysis of a new Tcrg haplotype with antibody responsiveness.	TRGC1 TRGC2	7.69e-07	2	31	2	1973682
Pubmed	Genetic loss of importin α4 causes abnormal sperm morphology and impacts on male fertility in mouse.	KPNA4 KPNA3	7.69e-07	2	31	2	33058343
Pubmed	Cellular Importin-α3 Expression Dynamics in the Lung Regulate Antiviral Response Pathways against Influenza A Virus Infection.	KPNA4 KPNA3	7.69e-07	2	31	2	32320654
Pubmed	T cell-specific gamma genes in C57BL/10 mice. Sequence and expression of new constant and variable region genes.	TRGC1 TRGC2	7.69e-07	2	31	2	3486244
Pubmed	Physical linkage of mouse Tcrg-V genes. II. Regulatory features of the Vg4-Vg3 intergenic region.	TRGC1 TRGC2	7.69e-07	2	31	2	8119740
Pubmed	Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-κB.	KPNA4 KPNA3	7.69e-07	2	31	2	28179530
Pubmed	Organization of the murine T-cell receptor gamma locus.	TRGC1 TRGC2	7.69e-07	2	31	2	8244371
Pubmed	The genomic arrangement of T cell receptor variable genes is a determinant of the developmental rearrangement pattern.	TRGC1 TRGC2	7.69e-07	2	31	2	14691262
Pubmed	New T-cell receptor gamma haplotypes in wild mice and evidence for limited Tcrg-V gene polymorphism.	TRGC1 TRGC2	7.69e-07	2	31	2	8420824
Pubmed	Developmentally ordered V-J recombination in mouse T cell receptor gamma locus is not perturbed by targeted deletion of the Vgamma4 gene.	TRGC1 TRGC2	7.69e-07	2	31	2	9126983
Pubmed	Conservation of Tcrg-V5 and limited allelic sequence polymorphism of the other Tcrg-V genes used by mouse tissue-specific gd-T lymphocytes.	TRGC1 TRGC2	7.69e-07	2	31	2	8550103
Pubmed	Limited diversity of the rearranged T-cell gamma gene.	TRGC1 TRGC2	7.69e-07	2	31	2	3871915
Pubmed	Mapping genomic organization by field inversion and two-dimensional gel electrophoresis: application to the murine T-cell receptor gamma gene family.	TRGC1 TRGC2	7.69e-07	2	31	2	3375073
Pubmed	Nuclear localization signal in a cancer-related transcriptional regulator protein NAC1.	KPNA4 KPNA3	2.31e-06	3	31	2	22665369
Pubmed	Langerhans cells are not required for epidermal Vgamma3 T cell homeostasis and function.	TRGC1 TRGC2	2.31e-06	3	31	2	21486908
Pubmed	Karyopherin α 3 and karyopherin α 4 proteins mediate the nuclear import of methyl-CpG binding protein 2.	KPNA4 KPNA3	2.31e-06	3	31	2	26245896
Pubmed	Genetic polymorphism and exon changes of the constant regions of the human T-cell rearranging gene gamma.	TRGC1 TRGC2	2.31e-06	3	31	2	2879283
Pubmed	Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3.	KPNA4 KPNA3	2.31e-06	3	31	2	10100610
Pubmed	Importin α3 regulates chronic pain pathways in peripheral sensory neurons.	KPNA4 KPNA3	4.61e-06	4	31	2	32792398
Pubmed	MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection.	KPNA4 KPNA3	4.61e-06	4	31	2	29370303
Pubmed	Subcellular distribution of importins correlates with germ cell maturation.	KPNA4 KPNA3	4.61e-06	4	31	2	17654710
Pubmed	Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein family.	KPNA4 KPNA3	4.61e-06	4	31	2	9395085
Pubmed	Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression.	KPNA4 KPNA3	4.61e-06	4	31	2	19710421
Pubmed	Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22.	TRGC1 TRGC2	7.68e-06	5	31	2	15821084
Pubmed	Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal.	KPNA4 KPNA3	7.68e-06	5	31	2	19961612
Pubmed	Identification of novel homologues of mouse importin alpha, the alpha subunit of the nuclear pore-targeting complex, and their tissue-specific expression.	KPNA4 KPNA3	7.68e-06	5	31	2	9369227
Pubmed	The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects.	HERC3 HERC4	7.68e-06	5	31	2	15676274
Pubmed	Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite.	KPNA4 KPNA3	7.68e-06	5	31	2	17981117
Pubmed	Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import.	KPNA4 KPNA3	1.15e-05	6	31	2	8551560
Pubmed	p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.	KPNA4 KPNA3	1.15e-05	6	31	2	2064827
Pubmed	A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal.	KPNA4 KPNA3	1.15e-05	6	31	2	15037073
Pubmed	Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation.	KPNA4 KPNA3	1.15e-05	6	31	2	8876228
Pubmed	Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.	KPNA4 KPNA3	1.15e-05	6	31	2	7745752
Pubmed	T cell receptor signaling for γδT cell development.	TRGC1 TRGC2	1.15e-05	6	31	2	30976362
Pubmed	HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.	KPNA4 KPNA3	1.15e-05	6	31	2	7859280
Pubmed	Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.	KPNA4 KPNA3	1.15e-05	6	31	2	9548947
Pubmed	Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.	KPNA4 KPNA3	1.15e-05	6	31	2	8529100
Pubmed	Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.	KPNA4 KPNA3	1.15e-05	6	31	2	8659115
Pubmed	Karyopherin alpha7 (KPNA7), a divergent member of the importin alpha family of nuclear import receptors.	KPNA4 KPNA3	1.15e-05	6	31	2	20701745
Pubmed	The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.	KPNA4 KPNA3	1.15e-05	6	31	2	9557700
Pubmed	A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.	KPNA4 KPNA3	1.15e-05	6	31	2	9603322
Pubmed	CNI-H0294, a nuclear importation inhibitor of the human immunodeficiency virus type 1 genome, abrogates virus replication in infected activated peripheral blood mononuclear cells.	KPNA4 KPNA3	1.15e-05	6	31	2	9593140
Pubmed	HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase.	KPNA4 KPNA3	1.15e-05	6	31	2	7585960
Pubmed	Three distinct classes of the alpha-subunit of the nuclear pore-targeting complex (importin-alpha) are differentially expressed in adult mouse tissues.	KPNA4 KPNA3	1.15e-05	6	31	2	10026238
Pubmed	The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.	KPNA4 KPNA3	1.15e-05	6	31	2	8041786
Pubmed	The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes.	KPNA4 KPNA3	1.15e-05	6	31	2	8041734
Pubmed	HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.	KPNA4 KPNA3	1.15e-05	6	31	2	9303297
Pubmed	Inhibition of nuclear import by backbone cyclic peptidomimetics derived from the HIV-1 MA NLS sequence.	KPNA4 KPNA3	1.15e-05	6	31	2	11904219
Pubmed	Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.	KPNA4 KPNA3	1.15e-05	6	31	2	9918876
Pubmed	Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection.	KPNA4 KPNA3	1.15e-05	6	31	2	9008157
Pubmed	Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import.	KPNA4 KPNA3	1.61e-05	7	31	2	10523667
Pubmed	Positive regulation of IkappaB kinase signaling by protein serine/threonine phosphatase 2A.	PPP2R1A CHUK	1.61e-05	7	31	2	16126728
Pubmed	Active nuclear import and cytoplasmic retention of activation-induced deaminase.	KPNA4 KPNA3	1.61e-05	7	31	2	19412186
Pubmed	Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase.	IL1R1 CHUK	1.61e-05	7	31	2	16286467
Pubmed	Stoichiometry of the murine gammadelta T cell receptor.	TRGC1 TRGC2	1.61e-05	7	31	2	16418397
Pubmed	Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.	TRGC1 TRGC2	1.61e-05	7	31	2	7477352
Pubmed	Highly homologous HERC proteins localize to endosomes and exhibit specific interactions with hPLIC and Nm23B.	HERC3 HERC4	1.61e-05	7	31	2	18535780
Pubmed	An actin-regulated importin α/β-dependent extended bipartite NLS directs nuclear import of MRTF-A.	KPNA4 KPNA3	2.15e-05	8	31	2	20818336
Pubmed	Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm.	KPNA4 KPNA3	2.15e-05	8	31	2	20015032
Pubmed	Importin α7 is essential for zygotic genome activation and early mouse development.	KPNA4 KPNA3	2.15e-05	8	31	2	21479251
Pubmed	Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.	KPNA4 KPNA3	2.15e-05	8	31	2	8552640
Pubmed	Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein.	KPNA4 KPNA3	2.76e-05	9	31	2	10366569
Pubmed	HIV-1 nuclear import: in search of a leader.	KPNA4 KPNA3	2.76e-05	9	31	2	10525473
Pubmed	The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA.	KPNA4 KPNA3	2.76e-05	9	31	2	10888652
Pubmed	HIV-1 nuclear import: in search of a leader.	KPNA4 KPNA3	2.76e-05	9	31	2	9366553
Pubmed	HIV-1 infection requires a functional integrase NLS.	KPNA4 KPNA3	2.76e-05	9	31	2	11389849
Pubmed	Changing expression and subcellular distribution of karyopherins during murine oogenesis.	KPNA4 KPNA3	2.76e-05	9	31	2	26399853
Pubmed	Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.	KPNA4 KPNA3	2.76e-05	9	31	2	1631159
Pubmed	Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex.	KPNA4 KPNA3	2.76e-05	9	31	2	10860744
Pubmed	Viral protein R regulates nuclear import of the HIV-1 pre-integration complex.	KPNA4 KPNA3	2.76e-05	9	31	2	9463369
Pubmed	Transportin 3 and importin α are required for effective nuclear import of HIV-1 integrase in virus-infected cells.	KPNA4 KPNA3	2.76e-05	9	31	2	21326825
Pubmed	Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import.	KPNA4 KPNA3	2.76e-05	9	31	2	12414950
Pubmed	A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.	KPNA4 KPNA3	2.76e-05	9	31	2	8105392
Pubmed	Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses.	KPNA4 KPNA3	2.76e-05	9	31	2	11035935
Pubmed	HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway.	KPNA4 KPNA3	2.76e-05	9	31	2	9275210
Pubmed	Characterization of the nuclear import pathway for HIV-1 integrase.	KPNA4 KPNA3	2.76e-05	9	31	2	11278458
Pubmed	14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1).	KPNA4 KPNA3	2.76e-05	9	31	2	15057270
Pubmed	Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import.	KPNA4 KPNA3	2.76e-05	9	31	2	12368302
Pubmed	mRNA export through an additional cap-binding complex consisting of NCBP1 and NCBP3.	KPNA4 KPNA3	3.44e-05	10	31	2	26382858
Pubmed	HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase.	KPNA4 KPNA3	3.44e-05	10	31	2	9282826
Pubmed	SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia.	KPNA4 KPNA3	3.44e-05	10	31	2	35021089
Pubmed	The HIV-1 passage from cytoplasm to nucleus: the process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration.	KPNA4 KPNA3	4.21e-05	11	31	2	22509482
Pubmed	Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes.	IL1R1 CHUK	4.21e-05	11	31	2	16354686
Pubmed	HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr.	KPNA4 KPNA3	4.21e-05	11	31	2	9562972
Pubmed	Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.	KPNA4 KPNA3	5.05e-05	12	31	2	7494303
Pubmed	CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species.	KPNA4 KPNA3	5.05e-05	12	31	2	14759373
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	KPNA4 NIFK PPP2R1A AQR KPNA3	5.55e-05	469	31	5	27634302
Pubmed	STAT5 is required for thymopoiesis in a development stage-specific manner.	TRGC1 TRGC2	5.96e-05	13	31	2	15294943
Pubmed	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response.	KPNA4 KPNA3	5.96e-05	13	31	2	34950606
Pubmed	Regulating the functions of the HIV-1 matrix protein.	KPNA4 KPNA3	6.95e-05	14	31	2	17411366
Pubmed	Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex.	KPNA4 KPNA3	8.02e-05	15	31	2	10964507
Pubmed	Protein Palmitoylation by ZDHHC13 Protects Skin against Microbial-Driven Dermatitis.	IL1R1 CHUK	1.30e-04	19	31	2	28017833
Pubmed	The human T-cell receptor gamma (TRG) genes.	TRGC1 TRGC2	1.76e-04	22	31	2	2527426
Pubmed	Exploring the link between MORF4L1 and risk of breast cancer.	CHUK KPNA3	2.10e-04	24	31	2	21466675
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KPNA4 SPG11 CLTCL1 SCIMP IL1R1 ZNF174 CHUK	2.27e-04	1442	31	7	35575683
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	KPNA4 GNL2 PREB NIFK RPP40 AQR KPNA3	2.86e-04	1497	31	7	31527615
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	KPNA4 GNL2 NIFK PPP2R1A ZNF174 KPNA3	2.86e-04	1049	31	6	27880917
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	GNL2 NIFK PLD1 EML5 ABCA12 KPNA3	3.98e-04	1116	31	6	31753913
Interaction	IER2 interactions	KPNA4 PPP2R1A KPNA3	1.81e-05	37	28	3	int:IER2
Interaction	PRKY interactions	SPG11 CLTCL1 HERC4 CHUK	4.01e-05	140	28	4	int:PRKY
Cytoband	7p14	TRGC1 TRGC2	1.90e-04	30	31	2	7p14
Cytoband	15q14	SPG11 AQR	5.09e-04	49	31	2	15q14
Cytoband	Ensembl 112 genes in cytogenetic band chr7p14	TRGC1 TRGC2	6.18e-03	174	31	2	chr7p14
GeneFamily	Armadillo repeat containing\|Importins	KPNA4 KPNA3	1.42e-04	18	18	2	596
GeneFamily	T cell receptor gamma locus at 7p14	TRGC1 TRGC2	2.14e-04	22	18	2	375
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	KPNA4 KPNA3	8.25e-04	43	18	2	409
ToppCell	367C-Lymphocytic-ILC-ILC-2\|367C / Donor, Lineage, Cell class and subclass (all cells)	PLD1 RPP40 TRGC1 TRGC2	6.13e-06	173	31	4	0451450605521fecb27a958628870d268adfb023
ToppCell	AT2_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	PLA2R1 SLC10A2 ABCA12	1.02e-04	131	31	3	ff4e618bd944f852bbd34438f740187aca82460f
ToppCell	3'_v3-blood-Lymphocytic_Invariant-Inducer-like\|blood / Manually curated celltypes from each tissue	PRKG1 IL1R1 TRGC1	1.49e-04	149	31	3	75422e1a22736375e9ef439db0b2a5efa3f653a3
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|390C / Donor, Lineage, Cell class and subclass (all cells)	GNL2 TRGC1 TRGC2	1.62e-04	153	31	3	ce7a23c687e9e7d83d244046de19c854caded09b
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TBX4 TRGC1 TRGC2	1.65e-04	154	31	3	e94cd11488003347120eacd3ced0a8923ed09ccc
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	WSCD2 SCIMP HERC4	1.91e-04	162	31	3	b46158e260bd2f35702cec73e3b035e8e9ec4469
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PREB TRGC1 TRGC2	1.98e-04	164	31	3	a5227971a71345854e0538e42da684de87febda0
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	PRKG1 PLD1 IL1R1	2.05e-04	166	31	3	773673a5d0430640439845b264740bfbbdad0cb2
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like\|GI_small-bowel / Manually curated celltypes from each tissue	PRKG1 PLD1 IL1R1	2.09e-04	167	31	3	3ae46c6363da76c8e1f5579e6027bf88ed637a44
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	WSCD2 PLA2R1 TBX4	2.17e-04	169	31	3	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	wk_15-18-Hematologic-Myeloid-GMP\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PLD1 TRGC1 TRGC2	2.24e-04	171	31	3	4b8b67c289898ae114a07a2147b5a6f8ec9dd308
ToppCell	T_cells-CD56_bright_CD16-_NK_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PRKG1 TBX4 IL1R1	2.28e-04	172	31	3	980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILCP\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	WSCD2 TRGC1 TRGC2	2.36e-04	174	31	3	5e6050d20a5b27640f6a200441125b8ceba123c8
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CABYR TBX4 TRGC2	2.36e-04	174	31	3	e70cc623a3a6aceec813ed852fec0c4240561133
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CABYR TBX4 TRGC2	2.36e-04	174	31	3	b6725086fe5a2b057c7c495ec63c970ac52c2580
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CABYR TBX4 TRGC2	2.36e-04	174	31	3	9bb8159a62640756d18ecbade3bf32bcbb7dd590
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL1R1 TRGC1 TRGC2	2.44e-04	176	31	3	238244294d08975df6bfa26b2b437db3654408ae
ToppCell	wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	WSCD2 PLA2R1 IL1R1	2.52e-04	178	31	3	a55130670aa95a87b833dd3cd2de461d779e4c06
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL1R1 TRGC1 TRGC2	2.56e-04	179	31	3	dd3cf8fd10dc257d933a7f45860dc2e244c158b7
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NIPAL3 ZNF174 TRGC2	2.56e-04	179	31	3	5787ffba96918db80256ced076a455a84ba01384
ToppCell	10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	IL1R1 TRGC1 TRGC2	2.61e-04	180	31	3	27672ac6a02172a31851f18decb9acffa8f5a703
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	WSCD2 EML5 ABCA12	2.74e-04	183	31	3	7e2bac8b005155888ff4b41ef2e1d975dc17abc7
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-ILCP\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL1R1 SERPINA9 TRGC1	2.74e-04	183	31	3	4a1e5bf58d2acd9dbceeef538b6851c1e5e91059
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like\|lymph-node_spleen / Manually curated celltypes from each tissue	PRKG1 IL1R1 TRGC1	2.78e-04	184	31	3	d97471a4fe17cba6880ccf1a04cc00c741558124
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL1R1 TRGC1 TRGC2	2.82e-04	185	31	3	e1fd66f4295056807aa29c0e4ce6b1a79cc8dfcf
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	WSCD2 EML5 ABCA12	2.87e-04	186	31	3	15f2e5905486e33f6f7b3b3e9758a0559e8c61ee
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL1R1 TRGC1 TRGC2	2.92e-04	187	31	3	42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	IL1R1 TRGC1 TRGC2	2.92e-04	187	31	3	f31d865ce2a21bdf64dbe29ee3e4505ab482604a
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PLA2R1 PRKG1 IL1R1	2.92e-04	187	31	3	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRKG1 TBX4 IL1R1	2.92e-04	187	31	3	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	IL1R1 TRGC1 TRGC2	3.01e-04	189	31	3	723c57f278919e8251d56b3d19411f9088319450
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	IL1R1 TRGC1 TRGC2	3.01e-04	189	31	3	960374f5fb278659500a7c948c3068a95dd62eb0
ToppCell	10x3'2.3-week_14-16-Lymphocytic_NK-T_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	IL1R1 TRGC1 TRGC2	3.05e-04	190	31	3	67fa7472ec534179087963177351552cc3c335eb
ToppCell	10x3'2.3-week_14-16-Lymphocytic_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	IL1R1 TRGC1 TRGC2	3.05e-04	190	31	3	094efcde2b037ae509298abb8b2b1d52f9c86a45
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PRKG1 IL1R1 TRGC1	3.15e-04	192	31	3	df4741e7684f010445f0224a1fd61aaa4fae02b3
ToppCell	control-Myeloid-Immature_Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PLD1 CLTCL1 TRGC1	3.15e-04	192	31	3	9f12b79d661ef0f57c2c924e8ecc24a46ea996d2
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	PRKG1 TBX4 IL1R1	3.20e-04	193	31	3	acad568621ed677031797b8c2e34dafea798d681
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_9\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NIFK PRKG1 SCIMP	3.20e-04	193	31	3	89c63dd5d97fbd92ea308405b7e8e630dda5158d
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_9\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NIFK PRKG1 SCIMP	3.20e-04	193	31	3	7842f29c16fe3a289ed3861fa570430142d2363f
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	PRKG1 TBX4 IL1R1	3.20e-04	193	31	3	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	PRKG1 TBX4 IL1R1	3.20e-04	193	31	3	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRKG1 TBX4 IL1R1	3.25e-04	194	31	3	28c5482da199bcee9e85258a88af453d9fdbd56a
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRKG1 TBX4 IL1R1	3.25e-04	194	31	3	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRKG1 TBX4 IL1R1	3.25e-04	194	31	3	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PRKG1 TBX4 IL1R1	3.30e-04	195	31	3	c5d2d9f12fd893331c9de261af30607d845d4f6a
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PLA2R1 PRKG1 IL1R1	3.30e-04	195	31	3	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PRKG1 IL1R1 TRGC1	3.30e-04	195	31	3	63e132fd6e4318299dd47bbe8ed3bf120efe46dd
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRKG1 TBX4 IL1R1	3.30e-04	195	31	3	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SPG11 TRGC1 TRGC2	3.40e-04	197	31	3	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	PLA2R1 PRKG1 IL1R1	3.40e-04	197	31	3	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	PLA2R1 PRKG1 IL1R1	3.45e-04	198	31	3	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRKG1 TBX4 IL1R1	3.45e-04	198	31	3	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	severe-Myeloid-Immature_Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CLTCL1 TRGC1 TRGC2	3.45e-04	198	31	3	e36303628af3139310c1d7a84d2919b7319bbda4
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRKG1 TBX4 IL1R1	3.45e-04	198	31	3	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	mLN-ILC\|mLN / Region, Cell class and subclass	PRKG1 IL1R1 TRGC1	3.50e-04	199	31	3	d6c299312c747fb1b7c53644c53efc03a5fffe85
ToppCell	mLN-(3)_ILC\|mLN / shred on region, Cell_type, and subtype	PRKG1 IL1R1 TRGC1	3.50e-04	199	31	3	00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	PRKG1 TBX4 IL1R1	3.50e-04	199	31	3	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	mLN-(3)_ILC-(30)_ILC\|mLN / shred on region, Cell_type, and subtype	PRKG1 IL1R1 TRGC1	3.50e-04	199	31	3	33ac6d77099076df01299be429f4ba96f2f34cc1
ToppCell	mLN-ILC-ILC\|mLN / Region, Cell class and subclass	PRKG1 IL1R1 TRGC1	3.50e-04	199	31	3	ab09a06cdea2597e9fe4b4b304655e9de4d433f6
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	WSCD2 PRKG1 IL1R1	3.55e-04	200	31	3	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	Caecum-ILC\|Caecum / Region, Cell class and subclass	PRKG1 IL1R1 TRGC1	3.55e-04	200	31	3	a9a1f03b4f415da860fb52eaedb07f0743692c98
ToppCell	(3)_ILC\|World / shred on Cell_type and subtype	PRKG1 IL1R1 TRGC1	3.55e-04	200	31	3	03554b3f323785b1e0b48fa32de0d92065dd798e
ToppCell	Caecum-ILC-ILC\|Caecum / Region, Cell class and subclass	PRKG1 IL1R1 TRGC1	3.55e-04	200	31	3	3ac18c3ef335cb83d6a826f6c7519a5e7804929d
ToppCell	Transverse-(3)_ILC-(30)_ILC\|Transverse / shred on region, Cell_type, and subtype	PRKG1 IL1R1 TRGC1	3.55e-04	200	31	3	528520dc98775aca6cc7568fedf5906ea55e0bea
ToppCell	Transverse-(3)_ILC\|Transverse / shred on region, Cell_type, and subtype	PRKG1 IL1R1 TRGC1	3.55e-04	200	31	3	c1ad7cb012e1c8911e417f7d64ca662c4f5010e0
ToppCell	Transverse-ILC\|Transverse / Region, Cell class and subclass	PRKG1 IL1R1 TRGC1	3.55e-04	200	31	3	eb04d6ad2270d3d9ac3d1fae1bb9bedc6fca38fe
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	WSCD2 PRKG1 IL1R1	3.55e-04	200	31	3	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	Transverse-ILC-ILC\|Transverse / Region, Cell class and subclass	PRKG1 IL1R1 TRGC1	3.55e-04	200	31	3	60ec185df2f1989bf8febf75b11c46a576829be3
ToppCell	Caecum-(3)_ILC\|Caecum / shred on region, Cell_type, and subtype	PRKG1 IL1R1 TRGC1	3.55e-04	200	31	3	6857863b3200162c250123688af2cba681afcb35
ToppCell	Caecum-(3)_ILC-(30)_ILC\|Caecum / shred on region, Cell_type, and subtype	PRKG1 IL1R1 TRGC1	3.55e-04	200	31	3	ccd323997613b65f0189c0c66d76fbf273e18c03
ToppCell	(30)_ILC\|World / shred on Cell_type and subtype	PRKG1 IL1R1 TRGC1	3.76e-04	204	31	3	bd9fbd278c05e396463704d711b60d47699e3c09
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Gfra2_(Zona_Incerta,_ventral_part_(ZIV))\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	SCIMP SERPINA9	5.74e-04	51	31	2	622a588dcf6f70c5e6b7133678c00fc68d70d6b5
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Gfra2_(Zona_Incerta,_ventral_part_(ZIV))-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	SCIMP SERPINA9	5.74e-04	51	31	2	734b7ba494e57a0958999581c805eb90b9bbbd5a
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Grin2c_(SNc)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ABCA12 MROH2A	9.30e-04	65	31	2	acc541e5a0e4be5ddd5702f191185c5b405b8762
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Prlr_(Entorhinal_cortex?)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CCDC60 MROH2A	9.30e-04	65	31	2	57d0d892dab8bc8465067feeff279c967a43b781
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Grin2c_(SNc)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ABCA12 MROH2A	9.30e-04	65	31	2	b8ab40d75b4078123cdffec2f5326cff65f67578
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Prlr_(Entorhinal_cortex?)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CCDC60 MROH2A	9.30e-04	65	31	2	aba26f607f35c2920cdf956309285ad9e7b758a7
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Cbln2_(Neuron.Slc17a6.Rora.Cbln2)\|Thalamus / BrainAtlas - Mouse McCarroll V32	ABCA12 MROH2A	9.88e-04	67	31	2	5202166895fd109ad0d7584fc35c74814a59ce2b
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PLA2R1 SERPINA9	2.49e-03	107	31	2	4a18261492371d19b8dbd403e197fdf64ef69392
ToppCell	COVID_non-vent-Lymphocytic-T_cell-Gamma_Delta_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TRGC1 TRGC2	2.54e-03	108	31	2	04bfb90634b691020f246a8afbebd3bf944d1e0e
ToppCell	(0)_NK/T_cells-(0)_T_CD8\|(0)_NK/T_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	TRGC1 TRGC2	2.58e-03	109	31	2	73b188278473a3b112d406657680267b17a5b712
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EML5 MROH2A	2.72e-03	112	31	2	456278fb92dd41820fde8cf27c68fec45e15f972
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	SPG11 HERC4	2.82e-03	114	31	2	670c9802a59b39241abf6f2c12a3d1844c7db5e5
ToppCell	LPS-IL1RA-Endothelial-Mes-Like\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	WSCD2 MROH2A	2.97e-03	117	31	2	5a23770806b4612bed4ae6fd716abdec7f7f56c6
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TRGC1 TRGC2	3.02e-03	118	31	2	c351e465ece4f3767b2c19e695eca3c263c68777
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|356C / Donor, Lineage, Cell class and subclass (all cells)	TRGC1 TRGC2	3.17e-03	121	31	2	4ec70ad316942d9ade7bbdbf0e117e7c52b59d90
ToppCell	frontal_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PLA2R1 PLD1	3.22e-03	122	31	2	c16110934172f174f4aefe14b81abce8514b30f0
ToppCell	frontal_cortex-Non-neuronal-pericyte_cell-Peri\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PLA2R1 PLD1	3.22e-03	122	31	2	006ac4f6807e688554d36557d29d5e5a0bc3c36f
ToppCell	frontal_cortex-Non-neuronal-pericyte_cell\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PLA2R1 PLD1	3.22e-03	122	31	2	f3d9a5893fdee3562880fb6fc132b88169a7d997
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRGC1 TRGC2	3.38e-03	125	31	2	34d5be868c9728cc4f9ce0d65acf0e50171d2587
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRGC1 TRGC2	3.38e-03	125	31	2	e112787b05d8147093357c9861877f6620b9e271
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TRGC1 TRGC2	3.54e-03	128	31	2	356da8c9b2b856c7a027fa6f4af90f77c81b16a6
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|367C / Donor, Lineage, Cell class and subclass (all cells)	TRGC1 TRGC2	3.70e-03	131	31	2	cc5b5afab8622e98f673fa116a226d930c295327
ToppCell	343B-Lymphocytic-CD8+_Cytotoxic_T-cell\|343B / Donor, Lineage, Cell class and subclass (all cells)	TRGC1 TRGC2	3.98e-03	136	31	2	b4a934feea46eeb10d407d1545bd225173078792
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PLA2R1 IL1R1	4.04e-03	137	31	2	9324b55eac55e0cc1e8e450a4b5374d12e9587a3
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PLA2R1 IL1R1	4.04e-03	137	31	2	032f8409d0d179e254c8ff632afbda78852a9889
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PLA2R1 IL1R1	4.04e-03	137	31	2	265a4a50e48b13c8b3b0730f818235f71fbd6baa
ToppCell	TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor\|TCGA-Testes / Sample_Type by Project: Shred V9	TBX4 SLC10A2	4.10e-03	138	31	2	f7c40156c34d2d910bbda5ba07540ad0f6f22981
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLD1 EML5	4.10e-03	138	31	2	611fe0fb284e12678f9c47a0bdbfc367a93c52b3
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TRGC1 TRGC2	4.16e-03	139	31	2	a542ef99ba57f364ea9707b3119e11f5a240034c
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	KPNA4 GNL2 PLD1 HERC4 ZNF174	5.11e-06	194	30	5	2504_DN
Drug	HYCRON linker	KPNA4 KPNA3	1.67e-05	5	30	2	CID011069636
Drug	CNI-H0294	KPNA4 KPNA3	1.67e-05	5	30	2	CID000073088
Drug	AC1LA3FM	KPNA4 KPNA3	2.51e-05	6	30	2	CID000480797
Drug	dmDBP	KPNA4 KPNA3	2.51e-05	6	30	2	CID005316801
Drug	Hcda	KPNA4 KPNA3	4.68e-05	8	30	2	CID005312573
Drug	Tat11	KPNA4 KPNA3	6.01e-05	9	30	2	CID000480142
Disease	osteoarthritis, knee, body mass index	WSCD2 TBX4	7.99e-04	41	30	2	EFO_0004340, EFO_0004616
Disease	childhood trauma measurement, alcohol consumption measurement	PLA2R1 HERC3	2.38e-03	71	30	2	EFO_0007878, EFO_0007979
Disease	amino acid measurement	PLA2R1 PRKG1 CLTCL1 ABCA12	4.71e-03	678	30	4	EFO_0005134

Protein segments in the cluster

Peptide	Gene	Start	Entry
LKKLVEKFGKEWAHA	PPP2R1A	466	P30153
KVPHWTKKQLHEEVK	ABCA12	1446	Q86UK0
KDLVKQFHQIKVEKW	CABYR	56	O75952
WAPHIKKKSPFDIKV	AQR	31	O60306
KFRENVPAWEIFKKK	AQR	101	O60306
QKWEHFITAPKTKKF	CCDC60	206	Q8IWA6
VHKELFKDWNIPFKQ	NIFK	126	Q9BYG3
SHPKEKINKEAVWFL	KPNA3	336	O00505
LKKEKPWKHLIFVLN	GNL2	241	Q13823
IGIIFIKEKWKPKDF	NIPAL3	116	Q6P499
WETFHEFPLEKKKKF	HERC3	966	Q15034
QPFTWHEKIKKKDPK	CHUK	226	O15111
LKNGVKDIQKHKWFE	PRKG1	606	Q13976
IFWEVFHELPLEKKK	HERC4	971	Q5GLZ8
HSVFQWKFIPERKLK	EML5	586	Q05BV3
QHKEKLWFVPAKVED	IL1R1	76	P14778
FVNHKWPQKAKIILK	SLC10A2	181	Q12908
KKHFFKGEVKKAWIP	MROH2A	1506	A6NES4
EKKPLKFDFLLAWHK	RPP40	171	O75818
KWEIAKPLKHKQVDE	SCIMP	51	Q6UWF3
KFFPDVIKIHWQEKK	TRGC1	36	P0CF51
KFFPDIIKIHWQEKK	TRGC2	36	P03986
EFKWQVKRKFKHFQE	PLD1	111	Q13393
KVWLIEKKKDTPKQH	PLA2R1	941	Q13018
VLVNHIFFKAKWEKP	SERPINA9	201	Q86WD7
KFKPQKMLEHLELFW	CLTCL1	1326	P53675
HENVPKVKESNIWKK	SPG11	671	Q96JI7
WKVPSLEKVLEFKAH	PREB	181	Q9HCU5
VEDFHRASKKPKQWV	ZNF174	121	Q15697
NIKVGLHEKELWKKF	TBX4	66	P57082
LDWLKFGKKVLVVHF	WSCD2	466	Q2TBF2
THPKEKINKEAVWFL	KPNA4	336	O00629